Oromucosal apomorphine exposure increased less than dose‐proportionally from 7 to 14 mg for C max and AUC 0‐inf , while C max showed a trend toward dose proportionality with a 90% CI of the geometric mean ratio of both dose levels of 0.77–1.12.
← all excerpts
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients.
1
—
—